ZA964652B - Naphthalene derivatives processes for the preparation thereof and intermediates therefor - Google Patents

Naphthalene derivatives processes for the preparation thereof and intermediates therefor

Info

Publication number
ZA964652B
ZA964652B ZA964652A ZA964652A ZA964652B ZA 964652 B ZA964652 B ZA 964652B ZA 964652 A ZA964652 A ZA 964652A ZA 964652 A ZA964652 A ZA 964652A ZA 964652 B ZA964652 B ZA 964652B
Authority
ZA
South Africa
Prior art keywords
preparation
naphthalene derivatives
intermediates therefor
derivatives processes
processes
Prior art date
Application number
ZA964652A
Other languages
English (en)
Inventor
Tatsuzo Ukita
Katsuo Ikezawa
Shinsuke Yamagata
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of ZA964652B publication Critical patent/ZA964652B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA964652A 1995-06-15 1996-06-15 Naphthalene derivatives processes for the preparation thereof and intermediates therefor ZA964652B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14928895 1995-06-15

Publications (1)

Publication Number Publication Date
ZA964652B true ZA964652B (en) 1996-12-12

Family

ID=15471914

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964652A ZA964652B (en) 1995-06-15 1996-06-15 Naphthalene derivatives processes for the preparation thereof and intermediates therefor

Country Status (21)

Country Link
US (3) US6005106A (de)
EP (1) EP0748805B1 (de)
KR (1) KR100435247B1 (de)
CN (1) CN1063748C (de)
AR (1) AR002483A1 (de)
AT (1) ATE164843T1 (de)
AU (1) AU706156B2 (de)
BG (1) BG62521B1 (de)
BR (1) BR9602802A (de)
CA (1) CA2178974C (de)
DE (1) DE69600221T2 (de)
ES (1) ES2116131T3 (de)
HK (1) HK1010116A1 (de)
HU (1) HU222340B1 (de)
IL (1) IL118469A (de)
MY (1) MY121606A (de)
NO (1) NO310109B1 (de)
RU (1) RU2129120C1 (de)
SG (1) SG47152A1 (de)
TW (1) TW349098B (de)
ZA (1) ZA964652B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID19155A (id) * 1996-12-13 1998-06-18 Tanabe Seiyaku Co Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya
JPH1171351A (ja) * 1997-08-29 1999-03-16 Ss Pharmaceut Co Ltd 置換キノロン誘導体及びこれを含有する医薬
US20050147534A1 (en) 1998-05-05 2005-07-07 Massachusetts Institute Of Technology Emissive sensors and devices incorporating these sensors
DE69939629D1 (de) 1998-05-05 2008-11-06 Massachusetts Inst Technology Emittierende Polymere und Vorrichtungen diese Polymere enthaltend
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
WO2002094320A1 (en) 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Therapeutic compositions for repairing chondropathy
WO2002094321A1 (en) * 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Compositions for promoting healing of bone fracture
TWI221838B (en) 2001-08-09 2004-10-11 Tanabe Seiyaku Co Pyrazinoisoquinoline compound or naphthalene compound
CA2468544A1 (en) * 2001-12-10 2003-06-19 Amgen Inc. Vanilloid receptor ligands
WO2003057689A1 (en) * 2002-01-02 2003-07-17 Fujisawa Pharmaceutical Co., Ltd. Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
PL375552A1 (en) * 2002-05-22 2005-11-28 Amgen Inc. Vanilloid receptor ligands and their medical applications
EP2270006A1 (de) * 2002-08-08 2011-01-05 Amgen, Inc Pyridazin-Derivate zur Verwendung als Vanilloidrezeptorliganden
WO2004080966A1 (ja) 2003-03-14 2004-09-23 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
CA2525843A1 (en) * 2003-05-16 2004-12-02 University Of Chicago Optical fractionation methods and apparatus
MXPA06003615A (es) * 2003-09-30 2006-06-05 Amgen Inc Ligandos del receptor vanilloide y su uso en tratamientos.
JP2007522233A (ja) * 2004-02-11 2007-08-09 アムジエン・インコーポレーテツド バニロイド受容体リガンド及び治療におけるそれらの使用
MY139645A (en) * 2004-02-11 2009-10-30 Amgen Inc Vanilloid receptor ligands and their use in treatments
NZ553696A (en) 2004-09-13 2010-02-26 Ono Pharmaceutical Co Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
US8617819B2 (en) 2004-09-17 2013-12-31 Massachusetts Institute Of Technology Polymers for analyte detection
TWI339578B (en) * 2004-10-29 2011-04-01 Mitsubishi Tanabe Pharma Corp Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
WO2006089311A1 (en) * 2005-02-15 2006-08-24 Amgen Inc. Vanilloid receptor ligands and their use in treatments
WO2006113769A1 (en) * 2005-04-15 2006-10-26 Amgen Inc. Vanilloid receptor ligands and their use in treatments
JP4658134B2 (ja) 2005-10-04 2011-03-23 田辺三菱製薬株式会社 光学活性4−ヒドロキシ−1,2,3,4−テトラヒドロキノリン化合物の製法
PT2371820E (pt) 2005-10-04 2013-10-16 Mitsubishi Tanabe Pharma Corp Composto de álcool cíclico opticamente activo e método para a sua preparação
AU2006300478B2 (en) * 2005-10-05 2010-06-17 Mitsubishi Tanabe Pharma Corporation Dermatitis treating agent
WO2007105637A1 (ja) 2006-03-10 2007-09-20 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2008042289A2 (en) 2006-09-29 2008-04-10 Massachusetts Institute Of Technology Polymer synthetic technique
US8802447B2 (en) 2006-10-05 2014-08-12 Massachusetts Institute Of Technology Emissive compositions with internal standard and related techniques
US20090215189A1 (en) 2006-10-27 2009-08-27 Massachusetts Institute Of Technology Sensor of species including toxins and chemical warfare agents
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
EP2144916A4 (de) * 2007-04-10 2012-01-04 Univ Pennsylvania Phen-naphthalen- und phen-chinolinderivate und ihre verwendung zur bindung und abbildung von amyloider plaque
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
JP5985475B2 (ja) 2011-06-28 2016-09-06 田辺三菱製薬株式会社 新規医薬組成物
JPWO2013027835A1 (ja) 2011-08-25 2015-03-19 田辺三菱製薬株式会社 光学活性ナフタレン化合物の製法
US11970440B1 (en) 2023-10-30 2024-04-30 King Faisal University 8-(3-chlorobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound
US11932593B1 (en) 2023-10-31 2024-03-19 King Faisal University 8-(3-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound
US11987543B1 (en) 2023-10-31 2024-05-21 King Faisal University 8-(4-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8502573D0 (sv) * 1985-05-23 1985-05-23 Jouko Kanakre Fluorescent lanthanide chelates useful as labels of physiologically active materials
JP3042156B2 (ja) * 1992-02-20 2000-05-15 田辺製薬株式会社 ナフタレン誘導体、その製法及びその合成中間体
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
DE59609705D1 (de) * 1995-03-03 2002-10-31 Rolic Ag Zug Photovernetzbare Naphthylderivate

Also Published As

Publication number Publication date
HU222340B1 (hu) 2003-06-28
US5969140A (en) 1999-10-19
SG47152A1 (en) 1998-03-20
HU9601652D0 (en) 1996-08-28
IL118469A0 (en) 1996-09-12
AU706156B2 (en) 1999-06-10
CA2178974C (en) 2006-06-06
MY121606A (en) 2006-02-28
NO310109B1 (no) 2001-05-21
DE69600221D1 (de) 1998-05-14
CA2178974A1 (en) 1996-12-16
DE69600221T2 (de) 1998-08-06
CN1063748C (zh) 2001-03-28
BG62521B1 (bg) 2000-01-31
BR9602802A (pt) 1998-10-06
ATE164843T1 (de) 1998-04-15
HUP9601652A1 (en) 1997-09-29
AR002483A1 (es) 1998-03-25
TW349098B (en) 1999-01-01
KR100435247B1 (ko) 2004-09-10
EP0748805A1 (de) 1996-12-18
ES2116131T3 (es) 1998-07-01
HK1010116A1 (en) 1999-06-11
KR970001343A (ko) 1997-01-24
AU5469396A (en) 1997-01-02
NO962527L (no) 1996-12-16
BG100656A (en) 1997-09-30
US6005106A (en) 1999-12-21
RU2129120C1 (ru) 1999-04-20
US6214996B1 (en) 2001-04-10
NO962527D0 (no) 1996-06-14
IL118469A (en) 2000-08-13
CN1142497A (zh) 1997-02-12
EP0748805B1 (de) 1998-04-08

Similar Documents

Publication Publication Date Title
SG47152A1 (en) Naphthalene derivatives process for the preparation thereof and intermediates therefor
AU1155695A (en) Antifungal agents, processes for the preparation thereof, and intermediates
IL113850A0 (en) Process and intermediates for the preparation of 3-aryluracils
HUP9603527A2 (en) 3-amino-2-mercaptobenzoic acid derivatives and processes for their and the intermediers preparation and the intermediers
HUP9901176A3 (en) Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives and their intermediates
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
HUP9600320A3 (en) Process and new intermediates for the preparation of triazolinon-derivatives
EG22402A (en) Oxime compounds their use and intermediates for their production
IL118992A0 (en) Process and intermediates for preparing norbenzomorphan derivatives
AU639825B2 (en) Substituted 1,2,4-triazinediones, processes for their preparation, intermediates therefor and their use
HUP0003019A3 (en) Process for preparing 4-substituted-1h-indole-3-glyoxamides and their intermediates
ZA9610853B (en) Processes and intermediates for preparing pharmaceuticals.
HUP0001444A3 (en) Process for preparing carboxamido-4-azasteroids and their intermediates
HUP9903814A3 (en) Process for the preparation of pesticides, intermediates and preparation thereof
ZA965709B (en) Benzylhydroxylamines and intermediates for their preparation.
ZA961972B (en) 3-Aryluracils and intermediates for their preparation.
HUP0003788A3 (en) Azacycloalkylalkanoyl pseudotetrapeptides intermediates and processes for preparation thereof
AU6226598A (en) Processes and intermediates for preparing 2-fluorothiophene derivatives
AU4708697A (en) Process for the preparation of eberconazol and intermediates thereof
GB2302691B (en) Oxaindene derivatives and process for the preparation thereof
ZA95962B (en) Antifungal agents processes for the preparation thereof and intermediates
HUP9601521A2 (en) Substituted quinoline-intermediates and process for preparation the same
HUP9601520A2 (en) Substituted quinoline-intermediates and process for preparation the same
EP0738707A3 (de) Dianilinoglutacondialdehyd-Verbindungen und Verfahren zu ihrer Herstellung
HK1026696A (en) New intermediates and process for the preparation thereof